Federal Health Minister Mustafa Kamal met with the representative of the World Health Organization in Pakistan, where progress towards achieving WHO Maturity Level 3 (ML-3) for DRAP was reviewed.
During the meeting, the WHO representative appreciated Mustafa Kamal’s leadership and commitment to ongoing reforms in the health sector and described the federal cabinet’s approval of Pakistan’s first National Vaccine Policy as a historic step for the country’s healthcare sector.
The Federal Health Minister said that the technical assistance provided by the World Health Organization in Pakistan’s efforts to achieve WHO Maturity Level 3 is commendable.
Mustafa Kamal stated that a high-level meeting with the chief ministers of all provinces will be held in the coming days to review progress towards achieving WHO Maturity Level 3 and to further strengthen effective coordination between the federal and provincial governments.
He said that Pakistan will achieve WHO Maturity Level 3 status by April 2027, which will bring greater international recognition to the country’s pharmaceutical industry.
According to the Federal Health Minister, this achievement will facilitate Pakistan’s access to pharmaceutical markets in approximately 160 countries and will significantly enhance pharmaceutical exports and global competitiveness.
